Circulating DNA, a Potentially Sensitive and Specific Diagnostic Tool for Future Medicine
Liquid biopsy has the great potential of detecting early diseases before deterioration and is valued for screening abnormalities at early stage. In oncology, circulating DNA derived from shed cancer cells reflects the tissue of origin, so it could be used to locate tissue sites during early screenin...
Main Authors: | Fan Jiang, Xiaoxiao Yang, Xiping He, Mingming Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-11-01
|
Series: | Dose-Response |
Online Access: | https://doi.org/10.1177/1559325819891010 |
Similar Items
-
Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.
by: Raquel Jorge Ferreira Catarino
Published: (2019) -
Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.
by: Raquel Catarino, et al.
Published: (2012-01-01) -
The Future of DNA Diagnostics
by: Mark H. Skolnick
Published: (1999-01-01) -
The Future of DNA Diagnostics
by: Gregory C. Critchfield
Published: (1999-01-01) -
Towards Circulating-Tumor DNA-Based Precision Medicine
by: Ai Hironaka-Mitsuhashi, et al.
Published: (2019-09-01)